Company: DMAC
Filing Date: 2025-03-28
Form Type: DEF 14A
Source: 0001437749-25-009696
Chunk: 3

Company: DiaMedica Therapeutics Inc.
Filing Date: 2025-03-28
Form: DEF 14A
Chunk 3
---
 Public Accounting Firm and Authorization to Fix Remuneration | FOR         |             16 |      |
|                                                                                                                                                                         | Voting Proposal Three: Approval, on an Advisory (Non-Binding) Basis, of Executive Compensation     | FOR         |             18 |      |

<div align='center'>INTERNET AVAILABILITY OF PROXY MATERIALS</div>

Instead of mailing a printed copy of our proxy materials, including our Annual Report to Shareholders, to each shareholder of record, we have provided access to these materials in a fast and efficient manner via the Internet. We believe that this process expedites your receipt of our proxy materials, lowers the costs of our meeting and reduces the environmental impact of our meeting. On or about March 28, 2025, we expect to begin mailing a Notice of Internet Availability of Proxy Materials to shareholders of record as of March 18, 2025 and post our proxy materials on the website referenced in the Notice of Internet Availability of Proxy Materials (www.proxyvote.com). As more fully described in the Notice of Internet Availability of Proxy Materials, shareholders may choose to access our proxy materials at www.proxyvote.com or may request proxy materials in printed or electronic form. In addition, the Notice of Internet Availability of Proxy Materials and website provide information regarding how you may request to receive proxy materials in printed form by mail or electronically by email on an ongoing basis. For those who previously requested printed proxy materials or electronic materials on an ongoing basis, you will receive those materials as you previously requested.

<div align='center'>Important Notice Regarding the Availability of Proxy Materials
for the Annual General Meeting of Shareholders to be Held on May 15, 2025:
The Notice of Annual General Meeting of Shareholders and Proxy Statement and
Annual Report to Shareholders, including our Annual Report on Form 10-K
for the fiscal year ended December 31, 2024, are available at www.proxyvote.com.

1</div>

CORPORATE GOVERNANCE HIGHLIGHTS

| ✔       Annual election of directors            | ✔       Regular executive sessions                |
| ✔       Majority of independent directors       | ✔       No conflicts of interest                  |
| ✔       Independent Board Chairman              | ✔       Access to independent advisors            |
| ✔       Four fully independent Board committees | ✔       Independent compensation consultant       |
| ✔       Recent Board refreshment efforts        | ✔       Clawback policy                           |
| ✔       Recent Board leadership rotation        | ✔       No guaranteed salary increases or bonuses |
| ✔       Corporate governance guidelines